Korro Bio Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ram Aiyar
Chief executive officer
US$2.9m
Total compensation
| CEO salary percentage | 17.4% |
| CEO tenure | 4yrs |
| CEO ownership | 0.05% |
| Management average tenure | 2yrs |
| Board average tenure | less than a year |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$88m |
| Jun 30 2024 | n/a | n/a | -US$85m |
| Mar 31 2024 | n/a | n/a | -US$81m |
| Dec 31 2023 | US$3m | US$498k | -US$81m |
| Sep 30 2023 | n/a | n/a | -US$72m |
| Jun 30 2023 | n/a | n/a | -US$69m |
| Mar 31 2023 | n/a | n/a | -US$64m |
| Dec 31 2022 | US$1m | US$473k | -US$58m |
Compensation vs Market: Ram's total compensation ($USD2.86M) is above average for companies of similar size in the US market ($USD2.16M).
Compensation vs Earnings: Ram's compensation has increased whilst the company is unprofitable.
CEO
Ram Aiyar (46 yo)
4yrs
Tenure
US$2,858,230
Compensation
Mr. Ram Aiyar, Ph.D. MBA, serves as Director of Triveni Bio Inc. Mr. Aiyar has been President of Korro Bio, Inc. since November 20201, Director since November 03, 2023 and also has been its Chief Executive...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman of the Board | less than a year | US$534.53k | 0.37% $ 1.8m | |
| CEO, President & Director | 4yrs | US$2.86m | 0.049% $ 239.9k | |
| Co-Founder & Independent Director | no data | US$171.80k | no data | |
| Chief Financial Officer | 3.5yrs | US$1.32m | 0% $ 0 | |
| Co-Founder & Advisor | no data | no data | no data | |
| Co-Founder & Advisor | no data | no data | no data | |
| Chief Operating Officer | 1.3yrs | no data | no data | |
| Senior VP & General Counsel | no data | no data | no data | |
| Senior VP and Head of People & Culture | 2yrs | no data | no data | |
| VP & Head of CNS biology | no data | no data | no data | |
| Senior VP & Head of Platform | 2yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
2.0yrs
Average Tenure
49.5yo
Average Age
Experienced Management: KRRO's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman of the Board | less than a year | US$534.53k | 0.37% $ 1.8m | |
| CEO, President & Director | less than a year | US$2.86m | 0.049% $ 239.9k | |
| Co-Founder & Independent Director | less than a year | US$171.80k | no data | |
| Independent Director | less than a year | US$173.15k | no data | |
| Independent Director | less than a year | US$172.03k | no data | |
| Independent Director | less than a year | US$304.23k | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data |
0.6yrs
Average Tenure
56yo
Average Age
Experienced Board: KRRO's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.